Form 4 for NRSN NeuroSense Therapeutics Ltd.
Accepted 2026-04-01 16:26:11 ET · period of report 2026-03-26 · accession 0001213900-26-038545 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-01 16:26 | 2026-03-26 | NRSN | Eisenberg Or | CFO | A - Grant | $0.00 | +200.0K | 1.25M | +19% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-03-26 | A | A | 200,000 | $0.00 | 1,254,050 | D | — | — | (F1) The restricted shares vest in equal quarterly installments over a two-year period, commencing on the grant date of March 26, 2026, subject to the Reporting Person's continued service to the Issuer as of such vesting date. |